1. Novartis to pay $678 to settle kickback claims — PhRMA sues Minnesota over insulin pricing law — Amgen Enbrel patents to be upheld through 2029 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Do you have 7 minutes to fill out a quick survey about ordering food for work? You’ll be entered into a raffle to win a $100 Amazon.com gift card as a thank you for your time. click here
    Dismiss Notice

It's so quiet on the SKM site. What is next?

Discussion in 'SkinMedica' started by Anonymous, Feb 21, 2014 at 12:09 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    It has never been this quiet before. No negative postings since the national meeting. Has anyone noticed that their SKM quota is down and the Latisse quota has sky rocketed. Sure, tell us that we will only have an increase this year of 15 % but our Latisse quota will increase by 40%. What is this a bait and switch. Are you for real? We all know what you are doing. It all evens out in the end. Maybe SKM quota will go down but jack up the Latisse quota. Yeah, that makes a lot of sense. It's not going to be any better this year. Just worse on the other end. How does this company stay in business.